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 2 
Abstract 16 
Invertebrate models provide several important advantages over their vertebrate counterparts including 17 
fewer legislative stipulations and faster, more cost-effective experimental procedures. Furthermore, 18 
various similarities between insect and mammalian systems have been highlighted. To obtain 19 
maximum use of invertebrate models in pharmacology, their fidelity as analogues of vertebrate systems 20 
requires verification. We utilised a flour beetle (Tenebrio molitor) – tapeworm (Hymenolepis diminuta) 21 
model to evaluate the efficacy of known anthelmintic compounds, praziquantel, mebendazole and 22 
levamisole against H. diminuta cysticercoid larvae in vitro. Inhibition of cysticercoid activity during 23 
the excystation procedure was used as a proxy for worm removal.  The effects of the three compounds 24 
mirrored their relative efficacy in treatment against adult worms in mammalian systems; however, 25 
further study is required to determine the fidelity of this model in relation to dose administered. The 26 
model precludes comparison of consecutive daily administration of pharmaceuticals in mammals due 27 
to cysticercoids not surviving outside of the host for multiple days. Treatment of beetles in vivo, 28 
followed by excystation of cysticercoids post dissection could potentially allow for such comparisons. 29 
Further model validation will include analysis of pharmaceutical efficacy in varying H. diminuta 30 
isolates and pharmaceutical dilution in solvents other than water. Notwithstanding, our results 31 
demonstrate that this model holds promise as a method to efficiently identify promising new cestocidal 32 
candidates.        33 
 34 
Key words 35 
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 37 
Introduction 38 
Mammal testing remains the gold standard to screen potential drug compounds for various 39 
toxicological and pharmacological effects in humans (Baumans 2004). The general public and the 40 
scientific community have however increasingly opposed the use of experimental animals and sought 41 
to Reduce, Refine and Replace (the 3R’s) vertebrate experimentation (Schuppli et al. 2004). The use of 42 
invertebrate models would constitute one method of Reduction or potentially Replacement (nc3rs 43 
2014). The invertebrate innate immune response to infection resembles that in humans (Hoffmann et al. 44 
1999; Kavanagh and Reeves 2007; Kimbrell and Beutler 2001), and insects have been used as 45 
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 3 
immunological research models (Pursall and Rolff 2011). As invertebrates are presently not subject to 46 
experimental animal legislation that applies to vertebrates, less administrative efforts are required to 47 
ensure appropriate standards of welfare (Kemp and Massey 2007). Furthermore, in many invertebrate 48 
species, particularly insects, experimental processes are often quicker and their high rate of 49 
reproduction means they can be produced in large quantities in a relatively short time resulting in faster 50 
dissemination of results (Scully and Bidochka 2006). Finally, laboratory space required is minimal due 51 
to much smaller housing stipulations involved in using insects (Steinert et al. 2003). 52 
 53 
The cosmopolitan rat tapeworm Hymenolepis diminuta Rudolphi, 1819 has been used as an 54 
experimental model for decades. Whilst it very rarely infects humans and is easily treatable (Tanowitz 55 
et al. 2001), it is often used as a teaching model for two reasons: i) the ease of maintenance of both 56 
stages of the parasitic life cycle (cysticercoid larvae in flour beetles and adult worm in rats), and ii) the 57 
helminth represents the same basic sequence of development as most other cestodes. Thus, the study of 58 
H. diminuta has made substantial contributions to our understanding of cestodes in general including 59 
their survival, reproduction and development strategies (Mansur et al. 2014). The use of an invertebrate 60 
intermediate host of this parasite enables the possibility of anthelmintic screening with limited use of 61 
vertebrates. Indeed, cysticercoids of H. diminuta isolated from infected beetles have been used to 62 
deduce mechanisms of cestocidal activity of plant derived cysteine proteinases (found in papaya and 63 
pineapple etc.) (Mansur et al. 2014) and condensed tannins (Dhakal et al. 2015). In addition, Novak 64 
and Evans (1978) demonstrated that mebendazole can retard development of H. diminuta cysticercoids 65 
when fed to Tribolium confusum du Val, 1863 beetles suggesting a similar mode of action of the drug 66 
towards the cysticercoid stage inside insects to the adult worm inside the mammalian host. 67 
 68 
If the pharmacologic and toxicological parameters of potential cestocidal compounds, including plant 69 
extracts, can be achieved using an insect – tapeworm model it could significantly increase the speed at 70 
which such compounds are available as alternatives to current anthelmintics as well as reducing the 71 
amount of vertebrates necessary for experiments.  72 
 73 
In this study, we assessed the usefulness of the Tenebrio molitor (Linneaus, 1758) -H. diminuta model 74 
as a proxy for the mammalian system by evaluating: 1) if the effects of the three commonly used 75 
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 4 
anthelmintics, praziquantel, mebendazole, and levamisole on cysticercoids of H. diminuta resemble the 76 
effects known from adult worms in the rat host (qualitative similarity), and 2) if varying concentrations 77 
of the pharmaceutical alter the inhibition of larval cestodes from insects as they do in mammalian 78 
systems (quantitative similarity). We assessed anticestodal effects as the rate of inhibition of in vitro 79 
excystation of cysticercoids when exposed to the physico-chemical conditions mimicking the digestive 80 
processes in the gastrointestinal tract of the rat.     81 
 82 
Praziquantel is a highly effective drug against adult cestodes in mammals (McKellar and Jackson 2004; 83 
Thomas and Grönnert 1977), and we therefore hypothesized a strong inhibitory effect of praziquantel 84 
on cysticercoid excystation. In contrast, mebendazole shows a moderate effect on adult cestodes 85 
(McCracken, Lipkowitz et al. 1992), but it is widely used to treat nematode infections in humans 86 
(Bennett and Guyatt 2000). Inhibitory effects of mebendazole on cysticercoid excystation are therefore 87 
only expected at relatively high concentrations. Levamisole is a nematicidal drug showing no effect on 88 
adult cestodes in mammals (Bennett, Behm et al. 1978), and it therefore served as a negative control in 89 
this study. 90 
 91 
Materials and methods 92 
Pharmaceutical formulation and application 93 
Stock solutions of praziquantel (Droncit
®
), mebendazole (Vermox
®
) and levamisole hydrochloride 94 
were mixed with Mill-Q
® 
water in order to create the desired concentrations of 0.05, 0.005, 0.0005 and 95 
0.00005%.  96 
 97 
Infected T. molitor beetles (infection protocol as in Dhakal et al. 2015) were dissected with 0.9% 98 
physiological saline in a petri dish. Cysticercoid cysts were counted then removed with a Pasture 99 
Pipette and placed in watch glasses (33 mm diameter, 7 mm deep). Ten cysts were placed in each of 15 100 
watch glasses containing either one of the 3 drugs at the 4 different concentrations or saline control. 101 
Three controls were prepared, one for each drug. No more than 4 cysticercoids from a single beetle 102 
were used per watch glass. Once all cysts had been positioned, saline was removed from the glass with 103 
a pipette and 0.5ml of the desired anthelmintic or saline was applied. Watch glasses were then placed 104 
on a Centromat
®
 rotating table for 60 minutes at 50 rpm at room temperature. The experiment was 105 
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 5 
repeated at three separate occasions, and these repeats were pooled for final analysis leading to 30 106 
observations for each pharmaceutical at each concentration. 107 
 108 
Excystation 109 
Cysticercoid excystation was achieved utilizing a modified existing protocol  (Goodchild and Davis 110 
1972). Briefly, anthelmintic was removed with a Pasteur Pipette and 2 ml HCl-Pepsin solution [2 ml 37 111 
% HCl, 20 ml 37°C 0.9 % saline, 0.8 g pepsin powder from porcine gastric mucosa (1:2500, Sigma 112 
Life Science)] was added to each watch glass and placed in an incubator at 37°C for 10 minutes. The 113 
HCl-Pepsin solution was then removed by pipette and the cysticercoids were washed 3 times with 114 
saline (approx. 2 ml), to remove any remaining acid, after which 1 ml of trypsin-taurocholate solution 115 
[0.1 g sodium taurocholate hydrate powder, 0.1 g trypsin powder from porcine pancreas, (97 %, Sigma 116 
Life Science), 10 ml warm phosphate-buffered saline (PBS) was added. The cysticercoids were then 117 
placed in the incubator at 37°C for 180 minutes. 118 
 119 
Cysticercoid observations 120 
Cysticercoids were graded on a 2-point scale; 0 – no visible sign of activity; or 1 – movement within 121 
the cysticercoid or full excystation, that is, protrusion of the scolex from the cysticercoid capsule. To 122 
differentiate between type 0 and 1, each cysticercoid was observed at 100 × magnification for 10 123 
seconds.  124 
 125 
Statistical analysis 126 
Paired comparisons, across all pharmaceuticals and concentrations (including their respective controls), 127 
were executed under a generalised (binomial) linear model, which provided information on statistical 128 
differences for each comparison (total pairs = 35, each having 30 observations). The analyses were 129 
conducted under PROC GENMOD in SAS 9.1 for Windows (SAS Institute, Cary NC, USA), which 130 
also provided information on the effect of concentrations for each pharmaceutical.  131 
 132 
Results and Discussion 133 
Across all concentrations, praziquantel was significantly more inhibitory than mebendazole (0.05% 134 
p=0.0128, 0.005% p=0.0128, 0.0005% p=0.0168 and 0.00005% p=0.0012) and levamisole (0.05% 135 
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 6 
p=0.0002, 0.005% p=0.0001, 0.0005% p=0.0002, 0.00005% p=0.0001). Mebendazole was only 136 
significantly more inhibitory against levamisole at the highest two concentrations (0.05% p=0.0114, 137 
0.005% p=0.0026, 0.0005% p=0.0960 and 0.00005% p=0.2274). The inhibitory effect on excystation 138 
was dose-dependent both for praziquantel (p=0.0001) and mebendazole (p=0.0001) but not for 139 
levamisole where no significant reduction in excystation was observed (p=0.0633) (Fig. 1). 140 
 141 
Thus, the greatest inhibitory effect of anthelmintic on cysticercoid activity was observed for 142 
praziquantel, followed by mebendazole whereas no significant inhibition could be demonstrated for 143 
levamisole. This trend was observed across all concentrations and indeed, qualitatively the drugs 144 
appear to be mirroring their comparative levels of efficacy in the mammalian system against adult 145 
cestodes (Bennett et al. 1978; Dayan 2003; McCracken et al. 1992; Thomas and Grönnert 1977). 146 
Furthermore, differing concentrations of the drugs in vitro have a significant affect on cysticercoid 147 
inhibition. This corresponds to mammalian models in which differing doses of pharmaceuticals 148 
administered result in varying worm expulsion efficacy. In rats, 100% reduction in H. diminuta worm 149 
burden has been demonstrated with 5 mg/kg praziquantel application, while 0.5 mg/kg resulted in a 150 
53% worm burden reduction (Thomas and Gönnert 1977).  In this study both praziquantel and 151 
mebendazole were observed to be significantly less inhibitory at lower concentrations. Due to this 152 
varying cysticercoid inhibition as a function of concentration, future studies could focus on calibrating 153 
concentrations in vitro with worm expulsion in mammals in an effort to enhance quantitative similarity 154 
of this model. Furthermore, the variability (or lack thereof) in pharmaceutical efficacy in different H. 155 
diminuta isolates should be considered as well as pharmaceutical dilutions in solvents other than water. 156 
 157 
When utilizing mebendazole against cestode infections a number of studies employ consecutive daily 158 
treatment of the drug (Maki and Yanagisawa 1985; McCracken et al. 1992; Varma et al. 1989). As 159 
cysticercoids will not survive outside of the host for multiple days, comparisons of such studies with 160 
this model are precluded. Treatment of beetles in vivo, followed by excystation of cysticercoids post 161 
dissection could potentially allow for such comparisons. 162 
 163 
Although the quantitative properties in relation to concentration administered need further exploration 164 
in the present model, our study demonstrates that the relative effects of the three anthelmintics in 165 
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 7 
mammalian systems were mirrored by the cysticercoid excystation assay. Therefore, this model has the 166 
potential to function as a rapid and cost-effective screening technique of anthelminthic candidates for 167 
further testing. Additionally, the T. molitor - H. diminuta model may significantly reduce the number of 168 
vertebrates needed for initial drug screening complying with the increasing demand for a reduction in 169 
the number of vertebrates used in biomedical research.  170 
 171 
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